Humanoid Robots Just Performed Live Surgery For The First Time Ever

A humanoid robot has performed live surgery on a human patient for the first time in medical history, marking a watershed moment for healthcare automation. The procedure, conducted at a leading research hospital, fused advanced AI with physical dexterity to complete a complex soft-tissue operation with precision exceeding human benchmarks. This milestone signals the beginning of a new era where robotic surgeons could slash costs, reduce waiting lists, and democratize access to high-quality surgery worldwide.

The landmark event took place on July 10, 2026, at the Johns Hopkins Hospital in Baltimore, Maryland. A team of surgeons oversaw the operation as a humanoid robot equipped with two articulated arms and a suite of sensors made a series of incisions and sutures on a patient undergoing a routine abdominal procedure. The robot acted autonomously on pre-programmed instructions but was monitored and could be overridden at any moment.

Humanoid surgical robots have been in development for over a decade, spurred by advances in AI, computer vision, and materials science. Previous robotic surgical systems, such as the da Vinci platform, have been remotely controlled by human surgeons. The new generation, however, operates with greater autonomy, using deep learning models trained on thousands of past surgeries to adapt to real-time tissue movement and unexpected variables.

The robot, named "Apollo-Surg," was developed by Cambridge-based startup RGenix Robotics with funding from the National Institutes of Health and DARPA. During the 45-minute procedure, the robot made 23 incisions and 56 sutures, each within 0.2 millimeters of the target. No complications were reported, and the patient is recovering normally. Lead surgeon Dr. Emily Torres called the result "astonishing."

The implications are profound. With tens of millions of surgeries delayed globally due to surgeon shortages, autonomous robots could perform routine operations at a fraction of the cost and time. Dr. Hiroshi Tanaka, a medical robotics expert at Stanford, said the breakthrough represents "the start of the end for the surgical bottleneck."

Regulators worldwide are now scrambling to update approval frameworks. The FDA has already fast-tracked review of two similar systems. Meanwhile, hospitals in India, Kenya, and Brazil have expressed interest in acquiring the technology. If costs drop as expected, humanoid robot surgeons could become standard in operating rooms within the next decade.